A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A (vol 16, 433, 2021)
Shahram Attarian,Peter Young,Thomas H. Brannagan,David Adams,Philip Van Damme,Florian P. Thomas, Carlos Casanovas,Jafar Kafaie,Celine Tard,Maggie C. Walter,Yann Pereon,David Walk, Amro Stino,Marianne de Visser,Camiel Verhamme,Anthony Amato,Gregory Carter,Laurent Magy, Jeffrey M. Statland,Kevin Felice ORPHANET JOURNAL OF RARE DISEASES（2024）
AI 理解论文
溯源树
样例
